Catheter Precision (VTAK) Shareholder's Equity (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Catheter Precision | 2.01 Mn | 1.20 Mn | 390,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.87% |
| Dec 31, 2025 | -1.93% |
| Sep 30, 2025 | 3.56% |
| Jun 30, 2025 | -17.27% |
| Mar 31, 2025 | -32.67% |
| Dec 31, 2024 | -8.33% |
| Sep 30, 2024 | -10.41% |
| Jun 30, 2024 | -22.71% |
| Mar 31, 2024 | -12.59% |
| Dec 31, 2023 | -3.08% |
| Sep 30, 2023 | -8.09% |
| Jun 30, 2023 | -33.66% |
| Mar 31, 2023 | 287.29% |
| Dec 31, 2022 | -25.98% |
| Sep 30, 2022 | 27.77% |
| Jun 30, 2022 | -45.93% |
| Mar 31, 2022 | 32.44% |
| Dec 31, 2021 | -36.55% |
| Sep 30, 2021 | 1.35% |
| Jun 30, 2021 | 40.40% |
| Mar 31, 2021 | -28.38% |
| Dec 31, 2020 | -30.75% |
| Sep 30, 2020 | 13.17% |
| Jun 30, 2020 | 1.93% |
| Mar 31, 2020 | -20.14% |
| Dec 31, 2019 | -20.58% |
| Sep 30, 2019 | -19.57% |
| Jun 30, 2019 | -13.21% |
| Mar 31, 2019 | -10.38% |
| Dec 31, 2018 | 929.56% |
| Sep 30, 2018 | -33.72% |
| Jun 30, 2018 | 209.78% |
| Mar 31, 2018 | -16.97% |